Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 321.66M P/E - EPS this Y 14.30% Ern Qtrly Grth -
Income -40.44M Forward P/E -10.81 EPS next Y -8.30% 50D Avg Chg 45.00%
Sales 174.5M PEG - EPS past 5Y - 200D Avg Chg 127.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -6.00%
Recommedations 1.70 Quick Ratio 0.65 Shares Outstanding 210.29M 52W Low Chg 618.00%
Insider Own 2.17% ROA -8.84% Shares Float 190.32M Beta 0.77
Inst Own 27.01% ROE - Shares Shorted/Prior 19.06M/18.95M Price 1.73
Gross Margin 82.29% Profit Margin -23.18% Avg. Volume 2,142,154 Target Price 5.50
Oper. Margin -19.99% Earnings Date Nov 6 Volume 2,121,982 Change -5.98%
About Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients. It offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. The company's product pipeline includes AKB-9090, a drug targeting critical-care indications; and AKB-10108, a drug targeting conditions related to premature birth. It has collaboration agreements with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Akebia Therapeutics, Inc. News
10/10/24 CMS Grants TDAPA Reimbursement for Vafseo® (vadadustat) beginning January 1, 2025
10/09/24 Akebia Therapeutics Inc (AKBA) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...
10/07/24 Akebia Therapeutics and U.S. Renal Care Sign Commercial Supply Contract to Enable Access to Vafseo® (vadadustat) for Patients on Dialysis
10/05/24 Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Path To Profitability
10/01/24 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/05/24 Akebia Therapeutics and U.S. Renal Care Initiate the VOICE Trial of Vafseo® (vadadustat) for Patients on Dialysis
09/02/24 Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year?
08/26/24 Here's Why You Should Consider Buying Akebia (AKBA) Stock
08/26/24 Akebia Therapeutics to Present at Upcoming Investor Conferences
08/19/24 Zacks Industry Outlook Highlights Corcept, Amneal, Bioventus, Foghorn and Akebia
08/16/24 5 Small Drug Stocks to Buy as Innovation Reaches Peak
08/15/24 Are Medical Stocks Lagging Acrivon Therapeutics, Inc. (ACRV) This Year?
08/10/24 Akebia Therapeutics, Inc. (NASDAQ:AKBA) Just Reported And Analysts Have Been Lifting Their Price Targets
08/08/24 Akebia Therapeutics (AKBA) Reports Q2 Loss, Lags Revenue Estimates
08/08/24 Akebia Therapeutics: Q2 Earnings Snapshot
08/08/24 Akebia Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
08/02/24 Akebia Therapeutics to Report Second Quarter 2024 Financial Results and Discuss Recent Business Highlights
07/11/24 Akebia Regains Full Rights to Sell Vafseo Tablets in US After Ending Licensing Deal With CSL Vifor
07/11/24 Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo® (vadadustat) Tablets
06/27/24 Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
AKBA Chatroom

User Image DonnyDonowitz Posted - 1 hour ago

$AKBA

User Image FappyHand Posted - 1 hour ago

$AKBA red is red, dung beetles

User Image CookieWatcher Posted - 3 hours ago

$AKBA red is green is red is green

User Image conchabullosa Posted - 3 hours ago

$AKBA

User Image Jan1010 Posted - 3 hours ago

$AKBA wow gr8 without any moment for 1.03 mil shares traded …someone is holding the price for a reason …

User Image asavasir Posted - 3 hours ago

$AKBA this Barcoding indicates a big move is coming

User Image GoldmanSlaps Posted - 3 hours ago

$AKBA we have been so patient here man I feel for all the longs hopefully we get paid soon

User Image istockoz Posted - 4 hours ago

$AKBA EOD likely to be 1.32! We may see 1.32 next hour or if all goes well we will see 1.32. We can also consider that if X happens it can reach 1.32 once again!

User Image Ton60 Posted - 5 hours ago

$AKBA

User Image ContractRich Posted - 5 hours ago

$AKBA @Bidzill check out the 1hr chart. Retest? Are we finally going to break out of the downtrend?

User Image JB_Research Posted - 5 hours ago

$AKBA Vafseo now also Medicare/Medicaid approved... (the product is expected to be available in January 2025) https://ir.akebia.com/news-releases/news-release-details/cms-grants-tdapa-reimbursement-vafseor-vadadustat-beginning

User Image gaboriar Posted - 5 hours ago

$AKBA Wen Ford Pinto?

User Image Powell6531 Posted - 6 hours ago

$AKBA $NLTX $NNVC $NUWE $TRVN 👀

User Image Dazedconfused12 Posted - 7 hours ago

$AKBA been pretty much in this price range for 6 months now

User Image TheGreedyGremlin Posted - 7 hours ago

$AKBA Some of yall when AKBA goes up 2 cents.

User Image TheGreedyGremlin Posted - 7 hours ago

$AKBA AKBA taking off

User Image Elamenape2 Posted - 7 hours ago

$AKBA that line is tight

User Image NCpilot172 Posted - 7 hours ago

$AKBA Most bizarre movement I’ve seen on a stock. I’ve got stocks that get less than 5k daily volume that move smoother than this. Yes, 400k or volume is light for this, but look at how it just goes back and forth. The daily chart looks like an illiquid option🤣🤣

User Image Ton60 Posted - 7 hours ago

$AKBA Ping-Pong

User Image Thickhog81 Posted - 7 hours ago

$AKBA accumulation…

User Image Anxietyy Posted - 7 hours ago

$AKBA

User Image DonnyDonowitz Posted - 8 hours ago

$AKBA

User Image Thickhog81 Posted - 9 hours ago

$AKBA decent volume in the first hour 310K… but we need more! I want my $2 💵💵 🚀🚀

User Image ROCKET123 Posted - 9 hours ago

$AKBA The arms are gassing out from the strangulation hold…hmmm💎

User Image gaboriar Posted - 10 hours ago

$AKBA I remember during the beginning of Covid thinking Tesla was over priced. Then just watched it skyrocket day after day month after month. Feel the same way about NVDA with the crazy P/S yet there she goes.

User Image King_JK Posted - 10 hours ago

$AKBA Let’s break my short-term goals first~! 7.5$🚀🚀🚀

User Image TulipTree Posted - 10 hours ago

$AKBA

User Image PharmaExpert Posted - 11 hours ago

$AKBA $10 yet! Zzzz

User Image ViperV22 Posted - 11 hours ago

$AKBA

User Image Anxietyy Posted - 12 hours ago

$AKBA fingers crossed for Davita PR or Fresenius

Analyst Ratings
HC Wainwright & Co. Buy Sep 6, 24
HC Wainwright & Co. Buy Aug 12, 24
HC Wainwright & Co. Buy Mar 28, 24
HC Wainwright & Co. Buy Mar 15, 24
HC Wainwright & Co. Buy Nov 17, 23
HC Wainwright & Co. Buy Sep 27, 23
HC Wainwright & Co. Buy Aug 28, 23
HC Wainwright & Co. Neutral Aug 11, 23
HC Wainwright & Co. Neutral Jun 21, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hadas Nicole R. SVP, Chief Legal Off.. SVP, Chief Legal Officer May 24 Sell 1.22 63,186 77,087 524,344 05/25/23
Dahan Michel SVP, Chief Operating.. SVP, Chief Operating Officer May 24 Sell 1.22 95,478 116,483 574,037 05/25/23
Butler John P. CEO and President CEO and President Feb 28 Sell 2.17 79,026 171,486 1,403,247 03/02/22
Burke Steven Keith SVP, Chief Medical O.. SVP, Chief Medical Officer Feb 28 Sell 2.17 15,056 32,672 217,663 03/02/22
Cotreau Violetta SVP, Chief Accountin.. SVP, Chief Accounting Officer Feb 28 Sell 2.15 3,946 8,484 29,121 03/02/22
Dahan Michel SVP, Chief Operating.. SVP, Chief Operating Officer Feb 28 Sell 2.17 21,533 46,727 297,017 03/02/22
Faulkingham Dell SVP, CCO SVP, CCO Feb 28 Sell 2.17 13,184 28,609 173,841 03/02/22
Hadas Nicole R. SVP, Chief Legal Off.. SVP, Chief Legal Officer Feb 28 Sell 2.17 21,062 45,705 304,241 03/02/22
Spellman David A SVP, CFO and Treasur.. SVP, CFO and Treasurer Feb 28 Sell 2.16 8,203 17,718 128,599 03/02/22
Faulkingham Dell CCO CCO Mar 02 Sell 3.4 6,749 22,947 128,825 03/02/21
Hadas Nicole R. SVP, Chief Legal Off.. SVP, Chief Legal Officer Mar 02 Sell 3.4 14,285 48,569 263,171 03/02/21